Get the Stockscreener App
10.66
0.05%
0.0049
Drugs Made In America Acquisition Corp stock is traded at $10.66, with a volume of 4,565.
It is up +0.05% in the last 24 hours and up +0.52% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.65
Open:
$10.65
24h Volume:
4,565
Relative Volume:
0.04
Market Cap:
$258.79M
Revenue:
-
Net Income/Loss:
$6.66M
P/E Ratio:
53.78
EPS:
0.1982
Net Cash Flow:
$-379.20K
1W Performance:
+0.09%
1M Performance:
+0.52%
6M Performance:
+2.70%
1Y Performance:
+4.41%
1-Day Range:
$10.65
$10.66
1-Week Range:
$10.63
$10.66
52-Week Range:
$10.17
$10.66
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
646-726-7074
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, CCXI, DMII
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.66 | 258.79M | 0 | 6.66M | -379.20K | 0.1982 |
LION
Lionsgate Studios Corp
|
13.47 | 3.91B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.27 | 1.83B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
18.81 | 899.00M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
15.55 | 866.14M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.10 | 643.37M | 0 | 8.58M | -1.11M | 0.134 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
Price to sales forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Enterprise value to EBIT forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
OACCU Stock Fund Price and Chart — NASDAQ:OACCU - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
Pfizer Inc. - Encyclopedia Britannica
NTWO PE Ratio & Valuation, Is NTWO Overvalued - Intellectia AI
Drugs Made In America Acquisition Corp. (DMAA) Holds Steady Near Support as SPAC Sector WatchesHedge Fund Exposure - dars.gov.et
DMAADrugs Made In America Acquisition Corp Volatility & Greeks - Finviz
DGICB Q1 2026 Earnings: EPS Misses Estimates by 29.6%, Stock UnchangedHealthcare Earnings Report - dars.gov.et
DMII Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Price to book forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
DMAA Holds Steady Near Trust Value as Quiet Trading ContinuesTriangle Correction - dars.gov.et
Price to sales forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
Feis Equities and Lawrence Feis disclose 5.08% ownership in DMAA (DMAA) - Stock Titan
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Drugs Made In America Acquisition II Units (DMIIU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QLEP Stock Price and Chart — NYSE:QLEP - TradingView
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 - TradingKey
Drugs Made In America Acquisition Corp. (DMAA) Holds Steady Near Resistance as SPAC Sentiment Remains CautiousHedge Fund Exposure - dars.gov.et
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIU - TradingView
Drugs Made In America Acquisition II Corp. Rights (DMIIR) Holds Flat at $0.10 Amid Low ActivityGrowth Factor - dars.gov.et
Drugs Made In America Acquisition Corp (DMAAU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PLMK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Drugs Made In America Acquisition Corp (DMAAR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Units - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):